Faculty Opinions recommendation of Propofol sedation with bispectral index monitoring is useful for endoscopic submucosal dissection: a randomized prospective phase II clinical trial.

Phase Ii ◽

Bispectral Index ◽

Phase Ii Clinical Trial ◽

Propofol Sedation ◽

Submucosal Dissection ◽

Faculty Opinions recommendation of Propofol sedation with bispectral index monitoring is useful for endoscopic submucosal dissection: a randomized prospective phase II clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717950068.793455322 ◽

2012 ◽

Author(s):

Steven Moss

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Bispectral Index ◽

Phase Ii Clinical Trial ◽

Propofol Sedation ◽

Submucosal Dissection ◽

Propofol sedation with bispectral index monitoring is useful for endoscopic submucosal dissection: a randomized prospective phase II clinical trial

Endoscopy ◽

10.1055/s-0032-1306776 ◽

2012 ◽

Vol 44 (06) ◽

pp. 584-589 ◽

Cited By ~ 26

Author(s):

T. Sasaki ◽

S. Tanabe ◽

M. Azuma ◽

A. Sato ◽

A. Naruke ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Bispectral Index ◽

Phase Ii Clinical Trial ◽

Propofol Sedation ◽

Submucosal Dissection ◽

A target-controlled infusion system with bispectral index monitoring of propofol sedation during endoscopic submucosal dissection

Endoscopy International Open ◽

10.1055/s-0034-1377519 ◽

2014 ◽

Vol 03 (01) ◽

pp. E2-E6

Author(s):

Atsushi Imagawa ◽

Hidenori Hata ◽

Morihito Nakatsu ◽

Akihiro Matsumi ◽

Eijiro Ueta ◽

...

Keyword(s):

Bispectral Index ◽

Propofol Sedation ◽

Submucosal Dissection ◽

Target Controlled Infusion ◽

Infusion System

Induced chemotherapy plus consolidative chemoradiotherapy is an optimal regimen for locally advanced pancreatic cancer A single institutional prospective phase II clinical trial

Pancreatology ◽

10.1016/j.pan.2018.05.367 ◽

2018 ◽

Vol 18 (4) ◽

pp. S136

Author(s):

Wenhui Lou ◽

Lili Wu ◽

Yuhong Zhou

Keyword(s):

Pancreatic Cancer ◽

Clinical Trial ◽

Phase Ii ◽

Locally Advanced ◽

Advanced Pancreatic Cancer ◽

Phase Ii Clinical Trial ◽

Locally Advanced Pancreatic Cancer ◽

Prospective Phase ◽

Optimal Regimen

Randomized, Open, Prospective, Phase II Clinical Trial of Doxorubicin (DOXO) vs. Trabectedin Plus Doxo in the First-Line Treatment of Patients (PTS) with Advanced Non-Operable and/or Metastatic Soft Tissue Sarcomas (STS): Geis-20 Study

Annals of Oncology ◽

10.1016/s0923-7534(20)34065-5 ◽

2012 ◽

Vol 23 ◽

pp. ix490 ◽

Cited By ~ 1

Author(s):

J. Martin Broto ◽

X. Garcia Del Muro ◽

A. Lopez-Pousa ◽

R. Las De Penas ◽

J. Maurel ◽

...

Keyword(s):

Clinical Trial ◽

Soft Tissue ◽

Phase Ii ◽

Soft Tissue Sarcomas ◽

Phase Ii Clinical Trial ◽

Line Treatment ◽

First Line ◽

Prospective Phase ◽

First Line Treatment

MBCL-41. TREATMENT FAILURE PATTERNS ACROSS MEDULLOBLASTOMA SUBGROUPS WITHIN A PROSPECTIVE PHASE II CLINICAL TRIAL OF RISK-ADAPTED, VOLUME-REDUCED RADIATION THERAPY AND DOSE-INTENSE CHEMOTHERAPY WITH STEM CELL SUPPORT

Neuro-Oncology ◽

10.1093/neuonc/noy059.437 ◽

2018 ◽

Vol 20 (suppl_2) ◽

pp. i126-i126

Author(s):

Christopher Tinkle ◽

John Lucas ◽

Sudharsan Srinivasan ◽

Parker Tumlin ◽

Arzu Onar-Thomas ◽

...

Keyword(s):

Clinical Trial ◽

Radiation Therapy ◽

Stem Cell ◽

Treatment Failure ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Stem Cell Support ◽

Failure Patterns ◽

Prospective Phase ◽

Cell Support

Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial

Infectious Diseases and Therapy ◽

10.1007/s40121-020-00341-2 ◽

2020 ◽

Vol 9 (4) ◽

pp. 913-926 ◽

Cited By ~ 3

Author(s):

Danyal Ibrahim ◽

Latha Dulipsingh ◽

Lisa Zapatka ◽

Reginald Eadie ◽

Rebecca Crowell ◽

...

Keyword(s):

Clinical Trial ◽

Patient Outcomes ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Factors Associated ◽

Good Patient ◽

The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial

British Journal of Cancer ◽

10.1038/bjc.2014.541 ◽

2015 ◽

Vol 112 (8) ◽

pp. 1326-1331 ◽

Cited By ~ 17

Author(s):

A P Algazi ◽

E Cha ◽

S M Ortiz-Urda ◽

T McCalmont ◽

B C Bastian ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Wild Type ◽

Prospective Phase ◽

Extended Survival

SU-E-T-591: Optimizing Quality Assurance in a Prospective Phase II Clinical Trial for Intermediate-Risk Prostate Cancer with Brachytherapy as Monotherapy Using a Paladium-103 Standed-Seed Nomogram

Medical Physics ◽

10.1118/1.3612553 ◽

2011 ◽

Vol 38 (6Part20) ◽

pp. 3625-3625

Author(s):

R Kudchadker ◽

T Pugh ◽

T Bruno ◽

W Du ◽

D Swanson ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Quality Assurance ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Intermediate Risk ◽

Risk Prostate Cancer ◽

Human papillomavirus (HPV) infection as a prognostic factor in patients with oropharyngeal squamous cell carcinoma treated in a prospective phase II clinical trial

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.6035 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 6035-6035 ◽

Cited By ~ 1

Author(s):

S. Jo ◽

A. Juhasz ◽

K. Zhang ◽

C. Ruel ◽

S. P. Wilczynski ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Human Papillomavirus ◽

Prognostic Factor ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Hpv Infection ◽

Phase Ii Clinical Trial ◽